New vessel formation in the context of cardiomyocyte regeneration - the role and importance of an adequate perfusing vasculature

Stem Cell Research

Volumn 13, Issue 3, 2014, Pages 666-682

  Michelis, Katherine C ^a   Boehm, Manfred ^b   Kovacic, Jason C ^a  

^a MOUNT SINAI SCHOOL OF MEDICINE   (United States)

^b NATIONAL HEART LUNG AND BLOOD INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANGIOGENESIS; CARDIAC STEM CELL; CELL REGENERATION; EMBRYONIC STEM CELL; ENDOTHELIUM CELL; HEART DEVELOPMENT; HEART FAILURE; HEART MUSCLE CELL; HEART MUSCLE ISCHEMIA; HEART MUSCLE REVASCULARIZATION; HEMANGIOBLAST; HEMATOPOIETIC STEM CELL; HUMAN; HYBERNATING MYOCARDIUM; MYOBLAST; NONHUMAN; PLURIPOTENT STEM CELL; REVIEW; STRAIN DIFFERENCE; TISSUE REPAIR; ANIMAL; BIOLOGICAL THERAPY; CORONARY BLOOD VESSEL; CYTOLOGY; HEART; HEART DISEASES; PATHOPHYSIOLOGY; PERFUSION;

ANIMALS; CELL- AND TISSUE-BASED THERAPY; CORONARY VESSELS; HEART; HEART DISEASES; HUMANS; MYOCYTES, CARDIAC; NEOVASCULARIZATION, PHYSIOLOGIC; PERFUSION;

EID: 84911413534     PISSN: 18735061     EISSN: 18767753     Source Type: Journal    
DOI: 10.1016/j.scr.2014.04.009     Document Type: Review

References (122)

1. Allman K.C., Shaw L.J., Hachamovitch R., Udelson J.E. Myocardial viability testing and impact of revascularization on prognosis in patients with coronary artery disease and left ventricular dysfunction: a meta-analysis. J. Am. Coll. Cardiol. 2002, 39:1151-1158.
2. Ambrose J.A., Tannenbaum M.A., Alexopoulos D., et al. Angiographic progression of coronary artery disease and the development of myocardial infarction. J. Am. Coll. Cardiol. 1988, 12:56-62.
3. Asahara T., Murohara T., Sullivan A., et al. Isolation of putative progenitor endothelial cells for angiogenesis. Science 1997, 275:964-967.
4. Banerjee I., Zhang J., Moore-Morris T., et al. Thymosin Beta 4 is dispensable for murine cardiac development and function. Circ. Res. 2012, 110:456-464.
5. Banerjee I., Morris T.M., Evans S.M., Chen J. Thymosin beta4 is not required for embryonic viability or vascular development. Circ. Res. 2013, 112:e25-e28.
6. Bart B.A., Shaw L.K., McCants C.B., et al. Clinical determinants of mortality in patients with angiographically diagnosed ischemic or nonischemic cardiomyopathy. J. Am. Coll. Cardiol. 1997, 30:1002-1008.
7. Bax J.J., Schinkel A.F., Boersma E., et al. Early versus delayed revascularization in patients with ischemic cardiomyopathy and substantial viability: impact on outcome. Circulation 2003, 108(Suppl. 1):II39-II42.
8. Beanlands R.S., Hendry P.J., Masters R.G., deKemp R.A., Woodend K., Ruddy T.D. Delay in revascularization is associated with increased mortality rate in patients with severe left ventricular dysfunction and viable myocardium on fluorine 18-fluorodeoxyglucose positron emission tomography imaging. Circulation 1998, 98:II51-II56.
9. Bearzi C., Leri A., Lo Monaco F., et al. Identification of a coronary vascular progenitor cell in the human heart. Proc. Natl. Acad. Sci. U. S. A. 2009, 106:15885-15890.
10. Beltrami A.P., Barlucchi L., Torella D., et al. Adult cardiac stem cells are multipotent and support myocardial regeneration. Cell 2003, 114:763-776.
11. Bito V., Heinzel F.R., Weidemann F., et al. Cellular mechanisms of contractile dysfunction in hibernating myocardium. Circ. Res. 2004, 94:794-801.
12. Bito V., Heinzel F.R., Claus P., et al. Alterations in excitation-contraction coupling in chronically ischemic or hibernating myocardium. Exp. Clin. Cardiol. 2005, 10:142-145.
13. Bito V., van der Velden J., Claus P., et al. Reduced force generating capacity in myocytes from chronically ischemic, hibernating myocardium. Circ. Res. 2007, 100:229-237.
14. Bolli R., Tang X.L., Sanganalmath S.K., et al. Intracoronary delivery of autologous cardiac stem cells improves cardiac function in a porcine model of chronic ischemic cardiomyopathy. Circulation 2013, 128:122-131.
15. Chalothorn D., Faber J.E. Strain-dependent variation in collateral circulatory function in mouse hindlimb. Physiol. Genomics 2010, 42:469-479.
16. Chalothorn D., Clayton J.A., Zhang H., Pomp D., Faber J.E. Collateral density, remodeling, and VEGF-A expression differ widely between mouse strains. Physiol. Genomics 2007, 30:179-191.
17. Chalothorn D., Zhang H., Smith J.E., Edwards J.C., Faber J.E. Chloride intracellular channel-4 is a determinant of native collateral formation in skeletal muscle and brain. Circ. Res. 2009, 105:89-98.
18. Chen C., Ma L., Linfert D.R., et al. Myocardial cell death and apoptosis in hibernating myocardium. J. Am. Coll. Cardiol. 1997, 30:1407-1412.
19. Chen Z., Rubin J., Tzima E. Role of PECAM-1 in arteriogenesis and specification of preexisting collaterals. Circ. Res. 2010, 107:1355-1363.
20. Chih S., Macdonald P.S., McCrohon J.A., et al. Granulocyte-Colony Stimulating Factor in Angina Patients to Stimulate Neovascularization (GAIN II) Trial: A randomized placebo-controlled crossover study. Heart 2012, 98:282-290.
21. Chong J.J., Chandrakanthan V., Xaymardan M., et al. Adult cardiac-resident MSC-like stem cells with a proepicardial origin. Cell Stem Cell 2011, 9:527-540.
22. Christoffels V.M., Pu W.T. Developing insights into cardiac regeneration. Development 2013, 140:3933-3937.
23. Cochain C., Channon K.M., Silvestre J.S. Angiogenesis in the infarcted myocardium. Antioxid. Redox Signal. 2013, 18:1100-1113.
24. Davies M.J. Anatomic features in victims of sudden coronary death. Coronary artery pathology. Circulation 1992, 85:I19-I124.
25. de Vries M.R., Seghers L., van Bergen J., et al. C57BL/6 NK cell gene complex is crucially involved in vascular remodeling. J. Mol. Cell. Cardiol. 2013, 64:51-58.
26. Delewi R., Andriessen A., Tijssen J.G., Zijlstra F., Piek J.J., Hirsch A. Impact of intracoronary cell therapy on left ventricular function in the setting of acute myocardial infarction: a meta-analysis of randomised controlled clinical trials. Heart 2013, 99:225-232.
27. Depre C., Kim S.J., John A.S., et al. Program of cell survival underlying human and experimental hibernating myocardium. Circ. Res. 2004, 95:433-440.
28. Deuse T., Peter C., Fedak P.W., et al. Hepatocyte growth factor or vascular endothelial growth factor gene transfer maximizes mesenchymal stem cell-based myocardial salvage after acute myocardial infarction. Circulation 2009, 120:S247-S254.
29. Ding B.S., Nolan D.J., Butler J.M., et al. Inductive angiocrine signals from sinusoidal endothelium are required for liver regeneration. Nature 2010, 468:310-315.
30. Ding B.S., Nolan D.J., Guo P., et al. Endothelial-derived angiocrine signals induce and sustain regenerative lung alveolarization. Cell 2011, 147:539-553.
31. Ding B.S., Cao Z., Lis R., et al. Divergent angiocrine signals from vascular niche balance liver regeneration and fibrosis. Nature 2014, 505:97-102.
32. Duran J.M., Makarewich C.A., Sharp T.E., et al. Bone-derived stem cells repair the heart after myocardial infarction through transdifferentiation and paracrine signaling mechanisms. Circ. Res. 2013, 113:539-552.
33. Fallavollita J.A., Jacob S., Young R.F., Canty J.M. Regional alterations in SR Ca(2+)-ATPase, phospholamban, and HSP-70 expression in chronic hibernating myocardium. Am. J. Physiol. 1999, 277:H1418-H1428.
34. Fallavollita J.A., Malm B.J., Canty J.M. Hibernating myocardium retains metabolic and contractile reserve despite regional reductions in flow, function, and oxygen consumption at rest. Circ. Res. 2003, 92:48-55.
35. Fang J., Chen L., Fan L., et al. Enhanced therapeutic effects of mesenchymal stem cells on myocardial infarction by ischemic postconditioning through paracrine mechanisms in rats. J. Mol. Cell. Cardiol. 2011, 51:839-847.
36. Felker G.M., Shaw L.K., O'Connor C.M. A standardized definition of ischemic cardiomyopathy for use in clinical research. J. Am. Coll. Cardiol. 2002, 39:210-218.
37. Fulton W.F. The Time Factor in the Enlargement of Anastomoses in Coronary Artery Disease. Scott. Med. J. 1964, 9:18-23.
38. Garcia S., Sandoval Y., Roukoz H., et al. Outcomes after complete versus incomplete revascularization of patients with multivessel coronary artery disease: a meta-analysis of 89,883 patients enrolled in randomized clinical trials and observational studies. J. Am. Coll. Cardiol. 2013, 62:1421-1431.
39. Gheorghiade M., Sopko G., De Luca L., et al. Navigating the crossroads of coronary artery disease and heart failure. Circulation 2006, 114:1202-1213.
40. Ginsberg M., James D., Ding B.S., et al. Efficient direct reprogramming of mature amniotic cells into endothelial cells by ETS factors and TGFbeta suppression. Cell 2012, 151:559-575.
41. Glaser R., Selzer F., Faxon D.P., et al. Clinical progression of incidental, asymptomatic lesions discovered during culprit vessel coronary intervention. Circulation 2005, 111:143-149.
42. Gupta R., Tongers J., Losordo D.W. Human studies of angiogenic gene therapy. Circ. Res. 2009, 105:724-736.
43. Hagensen M.K., Shim J., Thim T., Falk E., Bentzon J.F. Circulating endothelial progenitor cells do not contribute to plaque endothelium in murine atherosclerosis. Circulation 2010, 121:898-905.
44. Hare J.M., Fishman J.E., Gerstenblith G., et al. Comparison of allogeneic vs autologous bone marrow-derived mesenchymal stem cells delivered by transendocardial injection in patients with ischemic cardiomyopathy: the POSEIDON randomized trial. JAMA 2012, 308:2369-2379.
45. Head S.J., Farooq V., Serruys P.W., Kappetein A.P. The SYNTAX score and its clinical implications. Heart 2014, 100:169-177.
46. Heldman A.W., DiFede D.L., Fishman J.E., et al. Transendocardial mesenchymal stem cells and mononuclear bone marrow cells for ischemic cardiomyopathy: the TAC-HFT randomized trial. JAMA 2014, 311:62-73.
47. Helisch A., Wagner S., Khan N., et al. Impact of mouse strain differences in innate hindlimb collateral vasculature. Arterioscler. Thromb. Vasc. Biol. 2006, 26:520-526.
48. Henry T.D., Grines C.L., Watkins M.W., et al. Effects of Ad5FGF-4 in patients with angina: an analysis of pooled data from the AGENT-3 and AGENT-4 trials. J. Am. Coll. Cardiol. 2007, 50:1038-1046.
49. Higuchi D.A., Cahan P., Gao J., et al. Structural variation of the mouse natural killer gene complex. Genes Immun. 2010, 11:637-648.
50. Holmes D.R., Davis K.B., Mock M.B., et al. The effect of medical and surgical treatment on subsequent sudden cardiac death in patients with coronary artery disease: a report from the Coronary Artery Surgery Study. Circulation 1986, 73:1254-1263.
51. Houtgraaf J.H., de Jong R., Kazemi K., et al. Intracoronary infusion of allogeneic mesenchymal precursor cells directly after experimental acute myocardial infarction reduces infarct size, abrogates adverse remodeling, and improves cardiac function. Circ. Res. 2013, 113:153-166.
52. Hunt S.A., Abraham W.T., Chin M.H., et al. 2009 focused update incorporated into the ACC/AHA 2005 Guidelines for the Diagnosis and Management of Heart Failure in Adults: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines: developed in collaboration with the International Society for Heart and Lung Transplantation. Circulation 2009, 119:e391-e479.
53. Jeevanantham V., Butler M., Saad A., Abdel-Latif A., Zuba-Surma E.K., Dawn B. Adult bone marrow cell therapy improves survival and induces long-term improvement in cardiac parameters: a systematic review and meta-analysis. Circulation 2012, 126:551-568.
54. Jesty S.A., Steffey M.A., Lee F.K., et al. c-kit+precursors support postinfarction myogenesis in the neonatal, but not adult, heart. Proc. Natl. Acad. Sci. U. S. A. 2012, 109:13380-13385.
55. Kalra D.K., Zoghbi W.A. Myocardial hibernation in coronary artery disease. Curr. Atheroscler. Rep. 2002, 4:149-155.
56. Kalra D.K., Zhu X., Ramchandani M.K., et al. Increased myocardial gene expression of tumor necrosis factor-alpha and nitric oxide synthase-2: a potential mechanism for depressed myocardial function in hibernating myocardium in humans. Circulation 2002, 105:1537-1540.
57. Kattman S.J., Huber T.L., Keller G.M. Multipotent flk-1+ cardiovascular progenitor cells give rise to the cardiomyocyte, endothelial, and vascular smooth muscle lineages. Dev. Cell 2006, 11:723-732.
58. Kelly R.F., Cabrera J.A., Ziemba E.A., et al. Continued depression of maximal oxygen consumption and mitochondrial proteomic expression despite successful coronary artery bypass grafting in a swine model of hibernation. J. Thorac. Cardiovasc. Surg. 2011, 141:261-268.
59. Kocher A.A., Schuster M.D., Szabolcs M.J., et al. Neovascularization of ischemic myocardium by human bone-marrow-derived angioblasts prevents cardiomyocyte apoptosis, reduces remodeling and improves cardiac function. Nat. Med. 2001, 7:430-436.
60. Kovacic J.C., Boehm M. Resident vascular progenitor cells: an emerging role for non-terminally differentiated vessel-resident cells in vascular biology. Stem Cell Res. 2009, 2:2-15.
61. Kovacic J.C., Moore J., Herbert A., Ma D., Boehm M., Graham R.M. Endothelial progenitor cells, angioblasts, and angiogenesis-old terms reconsidered from a current perspective. Trends Cardiovasc. Med. 2008, 18:45-51.
62. Kovacic J.C., Macdonald P., Feneley M.P., et al. Safety and efficacy of consecutive cycles of granulocyte-colony stimulating factor, and an intracoronary CD133+ cell infusion in patients with chronic refractory ischemic heart disease: the G-CSF in angina patients with IHD to stimulate neovascularization (GAIN I) trial. Am. Heart J. 2008, 156:954-963.
63. Kovacic J.C., Mercader N., Torres M., Boehm M., Fuster V. Epithelial-to-mesenchymal and endothelial-to-mesenchymal transition: from cardiovascular development to disease. Circulation 2012, 125:1795-1808.
64. Kovacic J.C., Limaye A.M., Sartori S., et al. Comparison of six risk scores in patients with triple vessel coronary artery disease undergoing PCI: Competing factors influence mortality, myocardial infarction, and target lesion revascularization. Catheter. Cardiovasc. Interv. 2013, 82:855-868.
65. Lammert E., Cleaver O., Melton D. Induction of pancreatic differentiation by signals from blood vessels. Science 2001, 294:564-567.
66. Leobon B., Garcin I., Menasche P., Vilquin J.T., Audinat E., Charpak S. Myoblasts transplanted into rat infarcted myocardium are functionally isolated from their host. Proc. Natl. Acad. Sci. U. S. A. 2003, 100:7808-7811.
67. Lim H., Fallavollita J.A., Hard R., Kerr C.W., Canty J.M. Profound apoptosis-mediated regional myocyte loss and compensatory hypertrophy in pigs with hibernating myocardium. Circulation 1999, 100:2380-2386.
68. Ling L.F., Marwick T.H., Flores D.R., et al. Identification of therapeutic benefit from revascularization in patients with left ventricular systolic dysfunction: inducible ischemia versus hibernating myocardium. Circ. Cardiovasc. Imaging 2013, 6:363-372.
69. Lloyd-Jones D.M., Larson M.G., Leip E.P., et al. Lifetime risk for developing congestive heart failure: the Framingham Heart Study. Circulation 2002, 106:3068-3072.
70. Lui K.O., Zangi L., Silva E.A., et al. Driving vascular endothelial cell fate of human multipotent Isl1+ heart progenitors with VEGF modified mRNA. Cell Res. 2013, 23:1172-1186.
71. Luss H., Schafers M., Neumann J., et al. Biochemical mechanisms of hibernation and stunning in the human heart. Cardiovasc. Res. 2002, 56:411-421.
72. Mac Gabhann F., Peirce S.M. Collateral capillary arterialization following arteriolar ligation in murine skeletal muscle. Microcirculation 2010, 17:333-347.
73. Maes A., Flameng W., Nuyts J., et al. Histological alterations in chronically hypoperfused myocardium. Correlation with PET findings. Circulation 1994, 90:735-745.
74. Margariti A., Winkler B., Karamariti E., et al. Direct reprogramming of fibroblasts into endothelial cells capable of angiogenesis and reendothelialization in tissue-engineered vessels. Proc. Natl. Acad. Sci. U. S. A. 2012, 109:13793-13798.
75. Matsumoto K., Yoshitomi H., Rossant J., Zaret K.S. Liver organogenesis promoted by endothelial cells prior to vascular function. Science 2001, 294:559-563.
76. McClung J.M., McCord T.J., Keum S., et al. Skeletal muscle-specific genetic determinants contribute to the differential strain-dependent effects of hindlimb ischemia in mice. Am. J. Pathol. 2012, 180:2156-2169.
77. Menasche P., Alfieri O., Janssens S., et al. The Myoblast Autologous Grafting in Ischemic Cardiomyopathy (MAGIC) trial: first randomized placebo-controlled study of myoblast transplantation. Circulation 2008, 117:1189-1200.
78. Moretti A., Caron L., Nakano A., et al. Multipotent embryonic isl1+ progenitor cells lead to cardiac, smooth muscle, and endothelial cell diversification. Cell 2006, 127:1151-1165.
79. Ohle S.J., Anandaiah A., Fabian A.J., Fine A., Kotton D.N. Maintenance and repair of the lung endothelium does not involve contributions from marrow-derived endothelial precursor cells. Am. J. Respir. Cell Mol. Biol. 2012, 47:11-19.
80. Orlic D., Kajstura J., Chimenti S., et al. Bone marrow cells regenerate infarcted myocardium. Nature 2001, 410:701-705.
81. Page B., Young R., Iyer V., et al. Persistent regional downregulation in mitochondrial enzymes and upregulation of stress proteins in swine with chronic hibernating myocardium. Circ. Res. 2008, 102:103-112.
82. Pereira C.F., Chang B., Qiu J., et al. Induction of a hemogenic program in mouse fibroblasts. Cell Stem Cell 2013, 13:205-218.
83. Perin E.C., Willerson J.T., Pepine C.J., et al. Effect of transendocardial delivery of autologous bone marrow mononuclear cells on functional capacity, left ventricular function, and perfusion in chronic heart failure: the FOCUS-CCTRN trial. JAMA 2012, 307:1717-1726.
84. Pirolo J.S., Hutchins G.M., Moore G.W. Infarct expansion: pathologic analysis of 204 patients with a single myocardial infarct. J. Am. Coll. Cardiol. 1986, 7:349-354.
85. Proteau M.F., Rousselle E., Makrigiannis A.P. Mapping of the BALB/c Ly49 cluster defines a minimal natural killer cell receptor gene repertoire. Genomics 2004, 84:669-677.
86. Purhonen S., Palm J., Rossi D., et al. Bone marrow-derived circulating endothelial precursors do not contribute to vascular endothelium and are not needed for tumor growth. Proc. Natl. Acad. Sci. U. S. A. 2008, 105:6620-6625.
87. Qian L., Huang Y., Spencer C.I., et al. In vivo reprogramming of murine cardiac fibroblasts into induced cardiomyocytes. Nature 2012, 485:593-598.
88. Rafii S., Kloss C.C., Butler J.M., et al. Human ESC-derived hemogenic endothelial cells undergo distinct waves of endothelial to hematopoietic transition. Blood 2013, 121:770-780.
89. Rahimtoola S.H. A perspective on the three large multicenter randomized clinical trials of coronary bypass surgery for chronic stable angina. Circulation 1985, 72:V123-V135.
90. Rahimtoola S.H. The hibernating myocardium. Am. Heart J. 1989, 117:211-221.
91. Red-Horse K., Ueno H., Weissman I.L., Krasnow M.A. Coronary arteries form by developmental reprogramming of venous cells. Nature 2010, 464:549-553.
92. Rossdeutsch A., Smart N., Dube K.N., Turner M., Riley P.R. Essential role for thymosin beta4 in regulating vascular smooth muscle cell development and vessel wall stability. Circ. Res. 2012, 111:e89-e102.
93. Schulte S., Sukhova G.K., Libby P. Genetically programmed biases in Th1 and Th2 immune responses modulate atherogenesis. Am. J. Pathol. 2008, 172:1500-1508.
94. Senior R., Lahiri A., Kaul S. Effect of revascularization on left ventricular remodeling in patients with heart failure from severe chronic ischemic left ventricular dysfunction. Am. J. Cardiol. 2001, 88:624-629.
95. Shan K., Bick R.J., Poindexter B.J., et al. Altered adrenergic receptor density in myocardial hibernation in humans: A possible mechanism of depressed myocardial function. Circulation 2000, 102:2599-2606.
96. Sheridan C. Cardiac stem cell therapies inch toward clinical litmus test. Nat. Biotechnol. 2013, 31:5-6.
97. Shiojima I., Sato K., Izumiya Y., et al. Disruption of coordinated cardiac hypertrophy and angiogenesis contributes to the transition to heart failure. J. Clin. Invest. 2005, 115:2108-2118.
98. Sianos G., Morel M.A., Kappetein A.P., et al. The SYNTAX Score: an angiographic tool grading the complexity of coronary artery disease. EuroIntervention 2005, 1:219-227.
99. Simons M. Angiogenesis: where do we stand now?. Circulation 2005, 111:1556-1566.
100. Smart N., Riley P.R. Thymosin beta4 in vascular development response to research commentary. Circ. Res. 2013, 112:e29-e30.
101. Smart N., Risebro C.A., Melville A.A., et al. Thymosin beta4 induces adult epicardial progenitor mobilization and neovascularization. Nature 2007, 445:177-182.
102. Smart N., Risebro C.A., Clark J.E., et al. Thymosin beta4 facilitates epicardial neovascularization of the injured adult heart. Ann. N. Y. Acad. Sci. 2010, 1194:97-104.
103. Song K., Nam Y.J., Luo X., et al. Heart repair by reprogramming non-myocytes with cardiac transcription factors. Nature 2012, 485:599-604.
104. Stone G.W., Maehara A., Lansky A.J., et al. A prospective natural-history study of coronary atherosclerosis. N. Engl. J. Med. 2011, 364:226-235.
105. Takebe T., Sekine K., Enomura M., et al. Vascularized and functional human liver from an iPSC-derived organ bud transplant. Nature 2013, 499:481-484.
106. Tepper O.M., Capla J.M., Galiano R.D., et al. Adult vasculogenesis occurs through in situ recruitment, proliferation, and tubulization of circulating bone marrow-derived cells. Blood 2005, 105:1068-1077.
107. Tillmanns J., Rota M., Hosoda T., et al. Formation of large coronary arteries by cardiac progenitor cells. Proc. Natl. Acad. Sci. U. S. A. 2008, 105:1668-1673.
108. Traverse J.H., Henry T.D., Ellis S.G., et al. Effect of intracoronary delivery of autologous bone marrow mononuclear cells 2 to 3weeks following acute myocardial infarction on left ventricular function: the LateTIME randomized trial. JAMA 2011, 306:2110-2119.
109. Traverse J.H., Henry T.D., Pepine C.J., et al. Effect of the use and timing of bone marrow mononuclear cell delivery on left ventricular function after acute myocardial infarction: the TIME randomized trial. JAMA 2012, 308:2380-2389.
110. Uretsky B.F., Thygesen K., Armstrong P.W., et al. Acute coronary findings at autopsy in heart failure patients with sudden death: results from the assessment of treatment with lisinopril and survival (ATLAS) trial. Circulation 2000, 102:611-616.
111. van der Laan A.M., Hirsch A., Haeck J.D., et al. Recovery of microcirculation after intracoronary infusion of bone marrow mononuclear cells or peripheral blood mononuclear cells in patients treated by primary percutaneous coronary intervention the Doppler substudy of the Hebe trial. JACC Cardiovasc. Interv. 2011, 4:913-920.
112. Vanoverschelde J.L., Depre C., Gerber B.L., et al. Time course of functional recovery after coronary artery bypass graft surgery in patients with chronic left ventricular ischemic dysfunction. Am. J. Cardiol. 2000, 85:1432-1439.
113. Wald D.S., Morris J.K., Wald N.J., et al. Randomized trial of preventive angioplasty in myocardial infarction. N. Engl. J. Med. 2013, 369:1115-1123.
114. Wang S., Zhang H., Dai X., Sealock R., Faber J.E. Genetic architecture underlying variation in extent and remodeling of the collateral circulation. Circ. Res. 2010, 107:558-568.
115. Weyers J.J., Schwartz S.M., Minami E., et al. Effects of cell grafting on coronary remodeling after myocardial infarction. J. Am. Heart Assoc. 2013, 2:e000202.
116. Wu S.M., Fujiwara Y., Cibulsky S.M., et al. Developmental origin of a bipotential myocardial and smooth muscle cell precursor in the mammalian heart. Cell 2006, 127:1137-1150.
117. Xiong Q., Ye L., Zhang P., et al. Functional consequences of human induced pluripotent stem cell therapy: myocardial ATP turnover rate in the in vivo swine heart with postinfarction remodeling. Circulation 2013, 127:997-1008.
118. Zangi L., Lui K.O., von Gise A., et al. Modified mRNA directs the fate of heart progenitor cells and induces vascular regeneration after myocardial infarction. Nat. Biotechnol. 2013, 31:898-907.
119. Zbinden R., Zbinden S., Windecker S., Meier B., Seiler C. Direct demonstration of coronary collateral growth by physical endurance exercise in a healthy marathon runner. Heart 2004, 90:1350-1351.
120. Zbinden R., Zbinden S., Meier P., et al. Coronary collateral flow in response to endurance exercise training. Eur. J. Cardiovasc. Prev. Rehabil. 2007, 14:250-257.
121. Zhen F., Lan Y., Yan B., Zhang W., Wen Z. Hemogenic endothelium specification and hematopoietic stem cell maintenance employ distinct Scl isoforms. Development 2013, 140:3977-3985.
122. Ziegelhoeffer T., Fernandez B., Kostin S., et al. Bone marrow-derived cells do not incorporate into the adult growing vasculature. Circ. Res. 2004, 94:230-238.